nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—hypertension—focal segmental glomerulosclerosis	0.63	1	CtDrD
Furosemide—ALB—focal segmental glomerulosclerosis	0.179	1	CbGaD
Furosemide—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0568	0.578	CbGbCtD
Furosemide—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0416	0.423	CbGbCtD
Furosemide—Gout attack—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.304	CcSEcCtD
Furosemide—SLC12A1—nephron—focal segmental glomerulosclerosis	0.00665	0.16	CbGeAlD
Furosemide—SLC22A8—nephron—focal segmental glomerulosclerosis	0.00386	0.0927	CbGeAlD
Furosemide—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0369	CcSEcCtD
Furosemide—CA7—kidney—focal segmental glomerulosclerosis	0.00169	0.0405	CbGeAlD
Furosemide—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0316	CcSEcCtD
Furosemide—SLC22A11—nephron tubule—focal segmental glomerulosclerosis	0.00148	0.0355	CbGeAlD
Furosemide—SLC12A1—nephron tubule—focal segmental glomerulosclerosis	0.00143	0.0345	CbGeAlD
Furosemide—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00139	0.0334	CbGeAlD
Furosemide—SLCO2A1—nephron tubule—focal segmental glomerulosclerosis	0.00132	0.0318	CbGeAlD
Furosemide—SLC22A11—kidney—focal segmental glomerulosclerosis	0.0013	0.0312	CbGeAlD
Furosemide—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0248	CcSEcCtD
Furosemide—SLC22A11—cortex of kidney—focal segmental glomerulosclerosis	0.00126	0.0304	CbGeAlD
Furosemide—SLC12A1—kidney—focal segmental glomerulosclerosis	0.00126	0.0303	CbGeAlD
Furosemide—SLC12A1—cortex of kidney—focal segmental glomerulosclerosis	0.00123	0.0295	CbGeAlD
Furosemide—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00119	0.0286	CbGeAlD
Furosemide—PGD—nephron tubule—focal segmental glomerulosclerosis	0.00118	0.0284	CbGeAlD
Furosemide—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0229	CcSEcCtD
Furosemide—SLCO2A1—kidney—focal segmental glomerulosclerosis	0.00116	0.028	CbGeAlD
Furosemide—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0222	CcSEcCtD
Furosemide—SLCO2A1—cortex of kidney—focal segmental glomerulosclerosis	0.00113	0.0272	CbGeAlD
Furosemide—CA12—kidney—focal segmental glomerulosclerosis	0.0011	0.0263	CbGeAlD
Furosemide—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0206	CcSEcCtD
Furosemide—PGD—kidney—focal segmental glomerulosclerosis	0.00104	0.0249	CbGeAlD
Furosemide—PGD—cortex of kidney—focal segmental glomerulosclerosis	0.00101	0.0243	CbGeAlD
Furosemide—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.000985	0.0192	CcSEcCtD
Furosemide—CA1—kidney—focal segmental glomerulosclerosis	0.000868	0.0208	CbGeAlD
Furosemide—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.000863	0.0168	CcSEcCtD
Furosemide—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.000833	0.02	CbGeAlD
Furosemide—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.000813	0.0195	CbGeAlD
Furosemide—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000806	0.0157	CcSEcCtD
Furosemide—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.0156	CcSEcCtD
Furosemide—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.0153	CcSEcCtD
Furosemide—CA4—nephron tubule—focal segmental glomerulosclerosis	0.000772	0.0185	CbGeAlD
Furosemide—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.0148	CcSEcCtD
Furosemide—SLC22A8—kidney—focal segmental glomerulosclerosis	0.000732	0.0176	CbGeAlD
Furosemide—ABCC2—kidney—focal segmental glomerulosclerosis	0.000714	0.0172	CbGeAlD
Furosemide—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.000713	0.0171	CbGeAlD
Furosemide—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.000696	0.0167	CbGeAlD
Furosemide—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000687	0.0134	CcSEcCtD
Furosemide—CA4—kidney—focal segmental glomerulosclerosis	0.000678	0.0163	CbGeAlD
Furosemide—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000676	0.0132	CcSEcCtD
Furosemide—CA4—cortex of kidney—focal segmental glomerulosclerosis	0.000661	0.0159	CbGeAlD
Furosemide—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000649	0.0126	CcSEcCtD
Furosemide—CA2—nephron tubule—focal segmental glomerulosclerosis	0.00064	0.0154	CbGeAlD
Furosemide—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.00063	0.0151	CbGeAlD
Furosemide—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.0122	CcSEcCtD
Furosemide—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.000618	0.012	CcSEcCtD
Furosemide—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.0118	CcSEcCtD
Furosemide—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.0118	CcSEcCtD
Furosemide—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000568	0.0111	CcSEcCtD
Furosemide—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.011	CcSEcCtD
Furosemide—CA2—kidney—focal segmental glomerulosclerosis	0.000562	0.0135	CbGeAlD
Furosemide—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.0109	CcSEcCtD
Furosemide—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.0108	CcSEcCtD
Furosemide—SLC22A5—kidney—focal segmental glomerulosclerosis	0.000553	0.0133	CbGeAlD
Furosemide—CA2—cortex of kidney—focal segmental glomerulosclerosis	0.000548	0.0132	CbGeAlD
Furosemide—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.000539	0.0129	CbGeAlD
Furosemide—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.00991	CcSEcCtD
Furosemide—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.00952	CcSEcCtD
Furosemide—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00933	CcSEcCtD
Furosemide—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000472	0.0092	CcSEcCtD
Furosemide—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00896	CcSEcCtD
Furosemide—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000433	0.00845	CcSEcCtD
Furosemide—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00825	CcSEcCtD
Furosemide—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00801	CcSEcCtD
Furosemide—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00771	CcSEcCtD
Furosemide—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000371	0.00723	CcSEcCtD
Furosemide—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000368	0.00717	CcSEcCtD
Furosemide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.00705	CcSEcCtD
Furosemide—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.00682	CcSEcCtD
Furosemide—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.00664	CcSEcCtD
Furosemide—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00654	CcSEcCtD
Furosemide—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00637	CcSEcCtD
Furosemide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000322	0.00628	CcSEcCtD
Furosemide—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00032	0.00624	CcSEcCtD
Furosemide—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.00612	CcSEcCtD
Furosemide—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.006	CcSEcCtD
Furosemide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.00589	CcSEcCtD
Furosemide—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.00585	CcSEcCtD
Furosemide—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.00572	CcSEcCtD
Furosemide—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000293	0.0057	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.00539	CcSEcCtD
Furosemide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000272	0.0053	CcSEcCtD
Furosemide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.00524	CcSEcCtD
Furosemide—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.0052	CcSEcCtD
Furosemide—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.0051	CcSEcCtD
Furosemide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000261	0.00509	CcSEcCtD
Furosemide—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000259	0.00505	CcSEcCtD
Furosemide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00503	CcSEcCtD
Furosemide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000254	0.00496	CcSEcCtD
Furosemide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00024	0.00467	CcSEcCtD
Furosemide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.00462	CcSEcCtD
Furosemide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000232	0.00452	CcSEcCtD
Furosemide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00449	CcSEcCtD
Furosemide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00448	CcSEcCtD
Furosemide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000228	0.00445	CcSEcCtD
Furosemide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000228	0.00445	CcSEcCtD
Furosemide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.00428	CcSEcCtD
Furosemide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00425	CcSEcCtD
Furosemide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00413	CcSEcCtD
Furosemide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00411	CcSEcCtD
Furosemide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00411	CcSEcCtD
Furosemide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000197	0.00383	CcSEcCtD
Furosemide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00373	CcSEcCtD
Furosemide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00368	CcSEcCtD
Furosemide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00356	CcSEcCtD
Furosemide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00344	CcSEcCtD
Furosemide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00331	CcSEcCtD
Furosemide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.00328	CcSEcCtD
Furosemide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.00327	CcSEcCtD
Furosemide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00326	CcSEcCtD
Furosemide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.00309	CcSEcCtD
